Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

When are the BET factors the most sensitive to bromodomain inhibitors?

Saadi Khochbin

Transcription 2013, 4 (2): 54-7

The recent publication of two detailed studies of mouse spermatogenesis, either after chemical inhibition of the BET bromodomains, or in the context of genetic alterations of one specific BET member, Brdt, provides the unique opportunity to assess the functional impact of BET bromodomain inhibitors.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Identification of unique, differentiation stage-specific patterns of expression of the bromodomain-containing genes Brd2, Brd3, Brd4, and Brdt in the mouse testis. Enyuan Shang, Glicella Salazar, Thomas E Crowley, Xiang Wang, Rocio A Lopez, Xiangyuan Wang, Debra J Wolgemuth Gene Expression Patterns: GEP 2004, 4 (5): 513-9

Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells. Younis M Khan, Paul Kirkham, Peter J Barnes, Ian M Adcock PloS One 2014, 9 (4): e95051

Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1. Marie Jung, Martin Philpott, Susanne Müller, Jessica Schulze, Volker Badock, Uwe Eberspächer, Dieter Moosmayer, Benjamin Bader, Norbert Schmees, Amaury Fernández-Montalván, Bernard Haendler Journal of Biological Chemistry 2014 March 28, 289 (13): 9304-19

BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. Anna C Belkina, Barbara S Nikolajczyk, Gerald V Denis Journal of Immunology 2013 April 1, 190 (7): 3670-8

BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Daniela Boehm, Vincenzo Calvanese, Roy D Dar, Sifei Xing, Sebastian Schroeder, Laura Martins, Katherine Aull, Pao-Chen Li, Vicente Planelles, James E Bradner, Ming-Ming Zhou, Robert F Siliciano, Leor Weinberger, Eric Verdin, Melanie Ott Cell Cycle 2013 February 1, 12 (3): 452-62

Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors. Michele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, George W Wright, Wenming Xiao, Yibin Yang, Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, Jonathan M Keller, Dongbo Liu, Paresma R Patel, Marc Ferrer, Shivangi Joshi, Sujata Nerle, Peter Sandy, Emmanuel Normant, Craig J Thomas, Louis M Staudt Proceedings of the National Academy of Sciences of the United States of America 2014 August 5, 111 (31): 11365-70

The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Jan De Rijck, Christine de Kogel, Jonas Demeulemeester, Sofie Vets, Sara El Ashkar, Nirav Malani, Frederic D Bushman, Bart Landuyt, Steven J Husson, Katrien Busschots, Rik Gijsbers, Zeger Debyser Cell Reports 2013 November 27, 5 (4): 886-94

Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression. Charalambos Michaeloudes, Nicolas Mercado, Colin Clarke, Pankaj K Bhavsar, Ian M Adcock, Peter J Barnes, Kian Fan Chung Journal of Immunology 2014 May 15, 192 (10): 4913-4920

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Shaokun Shu, Charles Y Lin, Housheng Hansen He, Robert M Witwicki, Doris P Tabassum, Justin M Roberts, Michalina Janiszewska, Sung Jin Huh, Yi Liang, Jeremy Ryan, Ernest Doherty, Hisham Mohammed, Hao Guo, Daniel G Stover, Muhammad B Ekram, Jonathan Brown, Clive D'Santos, Ian E Krop, Deborah Dillon, Michael McKeown, Christopher Ott, Jun Qi, Min Ni, Prakash K Rao, Melissa Duarte, Shwu-Yuan Wu, Cheng-Ming Chiang, Lars Anders, Richard A Young, Eric Winer, Antony Letai, William T Barry, Jason S Carroll, Henry Long, Myles Brown, X Shirley Liu, Clifford A Meyer, James E Bradner, Kornelia Polyak Nature 2016 January 21, 529 (7586): 413-417

BET bromodomain proteins are required for glioblastoma cell proliferation. Chiara Pastori, Mark Daniel, Clara Penas, Claude-Henry Volmar, Andrea L Johnstone, Shaun P Brothers, Regina M Graham, Bryce Allen, Jann N Sarkaria, Ricardo J Komotar, Claes Wahlestedt, Nagi G Ayad Epigenetics: Official Journal of the DNA Methylation Society 2014, 9 (4): 611-20

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

When are the BET factors the most sensitive to bromodomain inhibitors?

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips